retatrutide triple agonist glp-1 gip glucagon phase 2 nejm 2023 G Agonists – Retatrutide. What is all the buzz? – Dr Girouard's Retatrutide for Obesity: Phase 2
Description
The FDA safety communication is one of the few recent actions to declare the drugs safer than originally believed
Eat 3-5 prunes on days when bowel function seems sluggish
Patients who took a GLP-1 drug fared better than those in a control group at keeping their blood glucose levels in a healthy range while also losing more weight than those who werent taking the drug
This may contribute to their therapeutic potential in mental health
Weight loss is never guaranteed, and individual results vary
Lose Weight by Treating Root Causes Weight gain is rarely about willpower
